[HTML][HTML] Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - Journal of translational medicine, 2020 - Springer
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - Journal of translational medicine, 2020 - pubmed.ncbi.nlm.nih.gov
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
[HTML][HTML] Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - Journal of Translational Medicine, 2020 - ncbi.nlm.nih.gov
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
[PDF][PDF] Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - 2020 - scholar.archive.org
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
[PDF][PDF] Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - 2020 - viduketha.nsf.gov.lk
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
[PDF][PDF] Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - 2020 - redemc.net
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - Journal of Translational Medicine, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> A severe pneumonia-associated respiratory
syndrome caused by a new coronavirus was identified in December 2019 (COVID-19) …
syndrome caused by a new coronavirus was identified in December 2019 (COVID-19) …
[HTML][HTML] Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - Journal of Translational …, 2020 - … -medicine.biomedcentral.com
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
Why tocilizumab could be an effective treatment for severe COVID-19?
B Fu, X Xu, H Wei - Journal of Translational Medicine, 2020 - search.proquest.com
A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
identified in December 2019 (COVID-19), spread rapidly and has become a world-wide …
[引用][C] Why tocilizumab could be an effective treatment for severe COVID‑19?
B Fu, X Xu, H Wei - 2020 - dl.nsf.gov.lk
Why tocilizumab could be an effective treatment for severe COVID‑19? Why tocilizumab could
be an effective treatment for severe COVID‑19? NSF DL Home → 7.COVID-19 → Journal …
be an effective treatment for severe COVID‑19? NSF DL Home → 7.COVID-19 → Journal …